Speakers from the world's largest organisations will share their needs & experiences with many world first announcements. Learn of the requirements and case studies from end users and hear all about the latest innovations from companies across the value chain. In total, hear insights from 250 speakers.
Sebastien leads the mechanical design efforts for the neural interface development at Galvani Bioelectronics.
Prior to his work at Galvani Bioelectronics, Sebastien worked in many areas of design engineering, across several countries. These include piezoelectric micro-systems in NOLIAC (Denmark) and Safran Electronics & Defense (France), before moving to implantable medical devices when he joined Sorin/LivaNova (France) to develop pacemaker and defibrillator systems, with specific focus on the leads and interfaces. Sebastien also spent 4 years at Medtronic (Netherlands) to work on the development of thin-film based leads and interfaces for deep brain stimulation.
Sebastien has a Master of Science in Mechanical and Microtechnoloy Engineering from the French National School of Mechanical Engineering and Microtechnology (ENSMM).
Formed through a partnership between global healthcare company, GSK, and leading technology company, Verily Life Sciences, Galvani Bioelectronics combines the complementary expertise of its parent companies to enable the research, development and commercialisation of bioelectronic therapies.
Bioelectronic medicine is an emerging scientific field, aiming to use tiny implantable devices to change precise electrical signals in nerves to treat a range of debilitating chronic diseases. Galvani Bioelectronics represents an important step change in the research and development of these medicines, combining GSK's discovery and development expertise and deep understanding of disease biology with Verily's world leading expertise in the miniaturisation of low power electronics, device development, data analytics and software development for clinical applications.